Allergan can be an industry leader in research and development, with among the broadest advancement pipelines in the pharmaceutical industry and a leading placement in the submission of generic product applications globally. The directors of Allergan accept responsibility for the information contained in this announcement. To the best of their knowledge and belief , the info within this announcement is in accordance with the facts and will not omit anything more likely to affect the import of such info.To purchase all of the exceptional shares of common stock of Advanced Medical Optics . The tender give expired at nighttime Eastern time on Tuesday, Feb. 24, 2009, and was not expanded. The depositary for the tender present has advised Abbott that a total of around 56,395,914 shares of AMO common stock were validly tendered rather than withdrawn . These shares, alongside the shares possessed by Abbott and its own wholly owned subsidiaries beneficially, represent approximately 93.5 % of AMO’s outstanding shares of common stock, or 83 approximately. 1 % on a completely diluted basis. All AMO shares that were validly tendered in the present and not properly withdrawn have already been recognized for payment.